Peter Salgo, MD, and the panelists discuss how barriers are currently affecting a physician’s decision to treat and manage obese patients despite the American Medical Association’s 2013 decision to recognize obesity as a disease.
Yehuda Handelsman, MD, FACP, FACE, FNLA, explains that although obesity is recognized as a disease, he is unable to properly manage his patients’ obesity because if he were to diagnose a patient for it, he would not be reimbursed. More than just metabolic issues, patients who are obese often have joint problems, breathing difficulties, and overall mobility problems that may require surgeries. Dr Handelsman further explains that physicians need to be able to manage patients in ways similar to how patients are managed for other chronic diseases.
Jeffrey D. Dunn, PharmD, MBA, adds that not every party will approach obesity in the same way. Dr Dunn explains that from a payer perspective, the focus on improving the management of obesity begins with leveling the playing field and establishing coordination between the different stakeholders.
Maria Lopes, MD, MS, discusses how physicians need access to better patient engagement resources and behavior modification tools. She adds that professionals need to gain access to resources that help them understand which treatment methods work and which ones don’t.
Dr Dunn concludes the discussion by explaining why the provider, patient, and payer need to work together to combat these issues and spread the risk.
Joanne Mizell: Lifestyle Modification Programs Take Holistic Aim at Metabolic Disease
May 1st 2024Joanne Mizell shares insurer strategies in addressing the escalating rates of metabolic diseases, highlighting the importance of holistic treatment methods like lifestyle modification programs, which integrate nutrition, physical activity, and community engagement.
Read More
Navigating Health Policy in an Election Year: Insights From Dr Dennis Scanlon
April 2nd 2024On this episode of Managed Care Cast, we're talking with Dennis Scanlon, PhD, the editor in chief of The American Journal of Accountable Care®, about prior authorization, price transparency, the impact of health policy on the upcoming election, and more.
Listen
USPSTF Lowers Age for Biennial Mammograms to 40, Citing Early Detection Benefit
April 30th 2024The USPSTF lowered the recommended starting age for mammograms from 50 to 40 years, citing moderate benefits for early detection in this age group. Disparities persist, especially for Black women, highlighting the need for improved access to health care and social support.
Read More
Makers of medical tests will have about 4 years to show the FDA that their new offerings deliver accurate results; after previously decreasing for 27 years, US tuberculosis (TB) cases increased every year since 2020; a US district judge rejected a challenge by Bristol Myers Squibb and Johnson & Johnson to the Medicare drug price negotiation program.
Read More